An Address Surfaces for India's Medical-Tourism Hub

India Japan Kaizen — Health & Beauty Bridge Series, Part 6

Part 5 closed with five threads left dangling: no funded project under May's ICMR-DST-AMED research pact, no dates for Advantage Healthcare India's ninth edition or Sanjeevani's promised fourfold expansion, no named Japanese tenant at YEIDA's Medical Device Park despite May's MEJ agreement, no address for the Union Budget's five regional medical-tourism hubs nearly nine months after the speech that promised them, and no Hindi or South Asian market in sight for the Japanese beauty-clinic group building exactly the inbound-language infrastructure this series says hospitals have no reason to build. A week spent chasing all five turned up something Part 5 itself should have caught: UP's own regional medical hub already had an address, cleared by YEIDA's board two months before Part 5 went looking for one. Everything else on the list is essentially unmoved, with one partial update on the device-park side and a sharper number attached to the beauty side's blind spot.

An Address Surfaces — Two Months Before Part 5 Went Looking

Start with the embarrassing part. Reporting from late July described a proposed ₹5,000 crore "UP Cares Jewar Regional Medical Hub" on roughly 200 acres in Gautam Buddha Nagar district, with the World Bank said to have drawn up a preliminary project report and a presentation to the state's Chief Secretary already postponed once. Three weeks later, on 17 August 2026, YEIDA's 92nd board meeting turned that proposal into something with a harder number attached: 500 acres across Sectors 13 and 14, cleared for a regional medical hub meant to house super-specialty hospitals, a medical college, research and AYUSH centres, diagnostics, and medical-tourism facilitation — nearly the exact ingredient list the Union Budget's February speech described for its five promised hubs. The acreage figures between the July proposal and the August board clearance don't fully reconcile in public reporting, and allotment to any operator, Indian or Japanese, hasn't begun. Nobody at the Ministry of AYUSH or the Ministry of Health has stood up and called Jewar one of the Budget's five — that link exists only in UP's own framing of the project. But it is the closest thing to an address this series has found, and Part 5, published more than two months after YEIDA's board meeting, missed it completely.

The Device Park Gets Sharper Teeth, Not a Tenant's Name

The same 17 August board meeting approved a device-testing facility at YEIDA's existing Medical Device Park — a separate, already-established 350-acre project in Sector 28 — built around the US FDA's Accreditation Scheme for Conformity Assessment, which lets devices tested at an ASCA-accredited lab clear US regulatory review without a separate American test. That matters more to export-minded manufacturers than to the inbound story this series tracks, but it's real progress on the park's underlying infrastructure. On the investment side, a YEIDA MedTech Investors' Meet in July secured roughly ₹500 crore in fresh commitments from twelve companies agreeing to set up units there. Neither that meet nor the coverage of the August board meeting names a single Japanese company among the new arrivals — the specific gap Part 5 flagged keeps being a gap, even as the park's acreage, testing capability, and investment totals all keep climbing around it.

Research and Events: Exactly Where Part 5 Left Them

AMED's own public calls-for-proposals page, checked again this week, still lists nothing involving ICMR — its most recent entries are a US-Japan Cooperative Medical Sciences Program call and an e-ASIA joint research call, neither mentioning India, and May's memorandum of cooperation still hasn't produced a joint call on either agency's site. FICCI's Advantage Healthcare India page still shows February's eighth edition as its most recent, and the Services Export Promotion Council's Sanjeevani materials still point to September's Bharat Mandapam edition as its latest. Neither a ninth AHCI nor the larger Sanjeevani that Commerce Minister Piyush Goyal described has a published date.

The Beauty Side Puts a Number on Its Own Blind Spot

SBC Medical, parent of Shonan Beauty Clinic and the company Part 5 covered for rolling out English- and Chinese-language inbound infrastructure, used its Q2 2026 earnings call to attach harder numbers to its global ambitions: international operations account for roughly 1% of group revenue today, against a stated target of more than 20% within three to five years. The company has named Singapore — built around its acquisition of local operator Aesthetic Healthcare — as the hub for that Asian expansion, and signed a consulting agreement with Thailand's BLEZ Asia, which runs more than twenty pharmacies and clinics there. Nothing in that buildout mentions India, Hindi, or South Asia. The blind spot Part 4 found in Tokyo's hospital-translation directories, and Part 5 found in SBC's own April rollout, is still there — now with a specific revenue target attached to the markets the company does intend to reach instead.

What's Still Missing

• Official confirmation that Jewar's 500-acre hub — or any site — is one of the Union Budget's five regional MVT hubs. UP's own announcements make the link; neither the Ministry of AYUSH nor the Ministry of Health has.
• A named Japanese company among the YEIDA Medical Device Park's tenants, as opposed to the park's general allotment and investment totals.
• A funded ICMR-AMED project or researcher placement under May's memorandum of cooperation.
• Dates for Advantage Healthcare India's ninth edition or Sanjeevani's next, larger edition — neither has been announced.
• Any Japanese beauty or hospital operator's inbound-language plan that reaches Hindi or South Asia, rather than stopping at English and Chinese.

If you work in medtech investment, health-tourism infrastructure, or cross-border language services for aesthetic and wellness clinics — get in touch. Closing the gap between what gets announced and what actually gets built is exactly the kind of work India Japan Kaizen exists to do.

This is Part 6 of India Japan Kaizen's Health & Beauty Bridge Series, publishing weekly. Part 7 will check whether Delhi names Jewar, or anywhere else, as one of the Budget's five regional hubs, whether YEIDA opens allotment on the 500 acres it has cleared, and whether a single Japanese company's name finally attaches to a plot at the Medical Device Park.